Literature DB >> 17260337

Bereitschaftspotential and movement-related potentials: origin, significance, and application in disorders of human movement.

James G Colebatch1.   

Abstract

The existence of a slow negative wave, the Bereitschaftspotential ("BP"), preceding voluntary movement by 1 second or more was first reported more than 40 years ago. There appears to be considerable interindividual differences, but there is general agreement that the initial negativity actually consists of two distinct phases. Uncertainty remains about many other properties and features of the response, including nomenclature, which makes the existing literature difficult to synthesize. The duration of the premovement negativity raises questions about how and when voluntary movement is initiated. Premovement negativities can also be seen before (predictably) externally paced movement, and these have similarities to the BP. Although lateralized generators exist, it is likely that the majority of the early component of the BP (BP1 or early BP), arises from the anterior supplementary motor area (SMA) and more rostral pre-SMA. The late phase of the BP (BP2 or late BP) is probably generated by activity in both the SMA proper and the contralateral motor cortex. Changes in the BP occur in several movement disorders, notably Parkinson's disease, in which the pattern is consistent with a failure of pre-SMA activation. The presence (or absence) of a clear preceding negativity can also have diagnostic importance for certain movement disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17260337     DOI: 10.1002/mds.21323

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  The nature of corticospinal paths driving human motoneurones during voluntary contractions.

Authors:  Jane E Butler; Thomas S Larsen; Simon C Gandevia; Nicolas T Petersen
Journal:  J Physiol       Date:  2007-08-16       Impact factor: 5.182

2.  The conscious experience of action and intention.

Authors:  Lars Strother; Sukhvinder Singh Obhi
Journal:  Exp Brain Res       Date:  2009-07-30       Impact factor: 1.972

3.  Functional networks for cognitive control in a stop signal task: independent component analysis.

Authors:  Sheng Zhang; Chiang-shan R Li
Journal:  Hum Brain Mapp       Date:  2011-03-01       Impact factor: 5.038

4.  Closed-loop intracranial stimulation alters movement timing in humans.

Authors:  Bartlett D Moore; Adam R Aron; Nitin Tandon
Journal:  Brain Stimul       Date:  2018-03-08       Impact factor: 8.955

5.  Motor and Visuospatial Attention and Motor Planning After Stroke: Considerations for the Rehabilitation of Standing Balance and Gait.

Authors:  Sue Peters; Todd C Handy; Bimal Lakhani; Lara A Boyd; S Jayne Garland
Journal:  Phys Ther       Date:  2015-04-30

6.  Internally generated preactivation of single neurons in human medial frontal cortex predicts volition.

Authors:  Itzhak Fried; Roy Mukamel; Gabriel Kreiman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

7.  Cortical Potentials Prior to Movement in Parkinson's Disease.

Authors:  Ashlesh Laxman Patil; Sanjay Kumar Sood; Vinay Goyal; Kanwal Preet Kochhar
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Applauding with closed hands: neural signature of action-sentence compatibility effects.

Authors:  Pia Aravena; Esteban Hurtado; Rodrigo Riveros; Juan Felipe Cardona; Facundo Manes; Agustín Ibáñez
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

9.  Neurocomputational account of how the human brain decides when to have a break.

Authors:  Florent Meyniel; Claire Sergent; Lionel Rigoux; Jean Daunizeau; Mathias Pessiglione
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

10.  Progressive recruitment of contralesional cortico-reticulospinal pathways drives motor impairment post stroke.

Authors:  Jacob G McPherson; Albert Chen; Michael D Ellis; Jun Yao; C J Heckman; Julius P A Dewald
Journal:  J Physiol       Date:  2018-02-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.